Calendar

pharmadog

Week of Mar 30, 2026

Apr 1, 2026approval151d agoBREXPIPRAZOLE — FDA approvalBREXPIPRAZOLE

Sponsor: AMNEAL. Form: TABLET. Route: ORAL

full page →BREXPIPRAZOLE →fda approvals ↗

Apr 1, 2026approval151d agoBREXPIPRAZOLE — FDA approvalBREXPIPRAZOLE

Sponsor: AMNEAL. Form: TABLET. Route: ORAL

full page →BREXPIPRAZOLE →fda approvals ↗

Apr 1, 2026approval151d agoBREXPIPRAZOLE — FDA approvalBREXPIPRAZOLE

Sponsor: AMNEAL. Form: TABLET. Route: ORAL

full page →BREXPIPRAZOLE →fda approvals ↗

Apr 1, 2026approval151d agoBREXPIPRAZOLE — FDA approvalBREXPIPRAZOLE

Sponsor: AMNEAL. Form: TABLET. Route: ORAL

full page →BREXPIPRAZOLE →fda approvals ↗

Apr 1, 2026approval151d agoFOUNDAYO (ORFORGLIPRON CALCIUM) — FDA approvalorforglipron calcium

Sponsor: ELI LILLY AND CO. Form: TABLET. Route: ORAL

full page →orforglipron calcium →fda approvals ↗

Apr 1, 2026approval151d agoPROCHLORPERAZINE EDISYLATE — FDA approvalPROCHLORPERAZINE EDISYLATE

Sponsor: SOMERSET THERAPS LLC. Form: INJECTABLE. Route: INJECTION

full page →PROCHLORPERAZINE EDISYLATE →fda approvals ↗

Apr 2, 2026approval150d agoNINTEDANIB ESYLATE — FDA approvalBoehringer Ingelheim Corp

Sponsor: DR REDDYS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Apr 2, 2026approval150d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

full page →ACETAZOLAMIDE →fda approvals ↗

Apr 2, 2026approval150d agoNINTEDANIB ESYLATE — FDA approvalOfev

Sponsor: SANDOZ. Form: CAPSULE. Route: ORAL

full page →Ofev →fda approvals ↗

Apr 2, 2026approval150d agoEYLEA HD (AFLIBERCEPT) — FDA approvalEYLEA HD

Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION

full page →EYLEA HD →fda approvals ↗

Apr 2, 2026approval150d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 2, 2026approval150d agoPALIPERIDONE — FDA approvalEskayef Pharmaceuticals Ltd

Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Apr 2, 2026approval150d agoNINTEDANIB ESYLATE — FDA approvalOfev

Sponsor: CIPLA. Form: CAPSULE. Route: ORAL

full page →Ofev →fda approvals ↗

Apr 2, 2026approval150d agoGABAPENTIN — FDA approvalGABAPENTIN

Sponsor: STRIDES PHARMA. Form: CAPSULE. Route: ORAL

full page →GABAPENTIN →fda approvals ↗

Apr 2, 2026approval150d agoNINTEDANIB ESYLATE — FDA approvalOfev

Sponsor: DEXCEL. Form: CAPSULE. Route: ORAL

full page →Ofev →fda approvals ↗

Apr 2, 2026approval150d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL

full page →ACETAZOLAMIDE →fda approvals ↗

Apr 2, 2026approval150d agoACETAZOLAMIDE — FDA approvalACETAZOLAMIDE

Sponsor: MANKIND PHARMA. Form: TABLET. Route: ORAL

full page →ACETAZOLAMIDE →fda approvals ↗

Apr 2, 2026approval150d agoNINTEDANIB ESYLATE — FDA approvalOfev

Sponsor: APOTEX. Form: CAPSULE. Route: ORAL

full page →Ofev →fda approvals ↗

Apr 3, 2026approval149d agoGLYCOPYRRONIUM TOSYLATE — FDA approvalJourney Medical Corp

Sponsor: PADAGIS US. Form: CLOTH. Route: TOPICAL

full page →fda approvals ↗

Apr 3, 2026approval149d agoPHENYLEPHRINE HYDROCHLORIDE — FDA approvalPHENYLEPHRINE HYDROCHLORIDE

Sponsor: BAXTER HLTHCARE CORP. Form: SOLUTION. Route: INTRAVENOUS

full page →PHENYLEPHRINE HYDROCHLORIDE →fda approvals ↗

Apr 3, 2026approval149d agoTYVASO (TREPROSTINIL) — FDA approvalUNITED THERAPEUTICS Corp

Sponsor: UNITED THERAP. Form: SOLUTION. Route: INHALATION

full page →fda approvals ↗

Apr 3, 2026approval149d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

Sponsor: PHARM ASSOC. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗

Week of Apr 6, 2026

Apr 6, 2026approval146d agoIMATINIB MESYLATE — FDA approvalInhibikase Therapeutics, Inc.

Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 6, 2026approval

← prev

page 377 of 380

Week of Mar 30, 2026

Week of Apr 6, 2026